These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Ongoing||2007-000776-16||Development of Tumor Infiltrating Lymphocytes in Patients with Metastatic melanoma||not-yet-due|
|Ongoing||2009-013406-13||First Line Therapy of Glioblastoma Multiforme with Surgical Resection, Irradiation Therapy, Temozolomide and Additional Tumour-Lysate Pulsed Dendritic Cell Vaccination. A Feasibility Phase II Study.||not-yet-due|
|Ongoing||2011-001512-65||A Phase II study of metronomic and targeted anti-angiogenesis therapy for children with recurrent/progressive medulloblastoma||not-yet-due|
|Completed, but no date Terminated||2011-004391-11||Treatment of metastatic renal cell carcinoma using interleukin-12 secreting dendritic cells. Phase I/II clinical trial.||bad-data|
|Exempt||2014-003388-39||COMBINED ANTITUMOR THERAPY WITH EX VIVO MANIPULATED DENDRITIC CELLS PRODUCING INTERLEUKIN-12 IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS WITH PROGRESSIVE, RECURRENT OR PRIMARILY METASTATIC HIGH-RISK TUM...||not-yet-due|
|Ongoing||2015-002584-41||RECURENT NEUROBLASTOMA AND EWING´S SARCOMA: TREOSULPHAN BASED HIGH DOSE CHEMOTHERAPY WITH AUTOLOGOUS PBSC SUPPORT||not-yet-due|
|Not reported||2016-002177-35||The effect of gabapentin used as a preemptive to the emergence and development chronic neuropathic pain in patients after spinal cord trauma||2019-02-22||due-trials|
|Ongoing||2020-002060-31||An international randomised trial of additional treatments for COVID-19 in hospitalised patients who are all receiving the local standard of care||not-yet-due|